Prostate cancer is the second-leading cause of death in men after lung cancer in the United States, accounting for about 10 percent of cancer death in men. The Canadian Cancer Society reports it is the third most common cause of cancer death in Canadian men (after lung and colorectal). However, when caught and treated early, the cure rate is greater than 90 percent, according to the Prostate Cancer Foundation.
Researchers and doctors at medical facilities in the United States and Canada are studying two procedures in treating prostate cancer. If you are male, aged 60 or older, and have a diagnosis of low-risk, localized prostate cancer, you may qualify for this study.
The purpose of the study is to compare the safety and effectiveness of a high-intensity focused ultrasound (HIFU) procedure to cryotherapy (freeze therapy), a standard-of-care, minimally invasive treatment for prostate cancer.
If you have questions, and would like to speak with someone today, please call:
